Beyond The Signature: Real Informed Consent In Med Management

A consent form can be signed in seconds, but the fear that follows a missing conversation can last for weeks or years. We talk about the moment clinicians and patients quietly confuse documentation with informed consent, and why that confusion shows up later as shame, silence, and stopped meds. If you work in mental health care or you take psychiatric medication yourself, this is a grounded look at how trust is built or lost in the small moments. 

We walk through the real-world side effects patients often struggle to say out loud: tremor that turns into a terrifying story about Parkinson’s disease, sexual side effects that hit intimacy and identity, and weight gain that reshapes confidence and relationships. We also reflect on tardive dyskinesia and the devastation of learning, years into treatment, that a risk was never discussed. The takeaway is not “tell patients everything” or “say less so no one worries.” It is learning how to offer context, name what matters, and make room for questions before patients feel forced to manage side effects alone by skipping doses or stopping treatment. 

We bring in motivational interviewing as a practical bridge: asking permission before giving information, checking how much detail is helpful today, and inviting patients into shared decision making. Consent becomes something living and revisitable as people age, priorities shift, new relationships begin, and new evidence emerges. 

Transcript

When Consent Becomes A Checkbox

Dr. Saundra Jain 0:05

Hi, and welcome to the human side of psychopharmacology. I'm Dr. Saundra Jain. Today I'd like to talk about something that most of us have done countless times. Signed a consent form. You know, we've signed them as patients ourselves, and we've asked our patients to sign them. But sometimes a conversation about consent, well, it happens, and then sometimes it doesn't. Often it's just another form to complete before moving on to what comes next. A box gets checked, and on we go. Increasingly, this is done electronically, which seems to create even more distance between the signature and the conversation it was meant to represent. You know, I often find myself wondering: is that really informed consent? Or have we simply confused a form with a conversation? Because here's what I've learned after years of working with people. The conversations that don't happen often have consequences. Consider this: the side effect no one prepared the patient for, a tremor that becomes a fear of Parkinson's disease, a sexual side effect that leaves someone wondering, what's wrong with me? And weight gain that quietly erodes a patient's confidence. And as we all know, it often leads to them stopping treatment. What about involuntary movements that emerge years later, leaving our patients wondering why no one ever told them this was a possibility? All the things that patients decide not to say out loud. Certainly we don't intend for that to happen. In training, obtaining consent, it's often taught as one step in initiating treatment. Granted, time is limited, patients are often overwhelmed. And psychopharmacology can be complicated. There's a lot to talk about. Things like benefits, risks, alternative treatments, monitoring, potential side effects. And we do all of that while sitting with another human being who may be frightened, depressed, anxious, psychotic, grieving, exhausted, or just simply trying to absorb the fact that they may need treatment. You know, I've come to believe that informed consent, it isn't a one-time event. It's not a signature, it's not a checkbox, and it's certainly not the end of a conversation. If anything, it's the beginning of one.

The Doorknob Effect And Silence

Dr. Saundra Jain 3:12

As a psychotherapist, I've really had the honor and privilege of hearing what my patients say after they're leaving the appointments with their prescribing clinician. You know, they'll tell me about the questions they almost asked. They'll mention the side effects they weren't sure really mattered enough to bring up. They'll talk about worries that they didn't want to burden anyone with, the assumptions they made about what their clinician would think, their uncertainty about taking a medicine, fears about what others would think about them. And I've started to notice a pattern. What goes unspoken has the power to shape outcomes just as much as what gets said out loud. I've also learned to pay attention to what I call the doorknob effect. Think about this or imagine this. The appointment is ending. The patient is moving towards the door, their hand literally on the doorknob, and then they turn and say, Oh, you know what, Sandra? There's one more thing. I kind of giggle because it's happened so many times. And I know you've encountered this as well. We all know this. The thing that almost wasn't said turns out to be the thing that mattered most. Thinking

Tremor Fear And Sexual Side Effects

Dr. Saundra Jain 4:40

about this, I remember a patient who developed a tremor shortly after starting a medication. And rather than calling their prescriber, she became increasingly frightened and worried. And she convinced herself that she was developing Parkinson's. Now, by the time she finally brought it up, this poor woman had spent weeks imagining a future that wasn't hers. What she didn't know was that tremors can sometimes occur as a medication side effect. She hadn't really been prepared for that possibility, and fear rushed in to fill the silence. But once she verbalized her fears, I encouraged her to contact her prescriber immediately so they could have this really important conversation. And with her permission, of course, I also notified the clinician to give them a heads up about what was happening. So just like you, I've seen similar things happen with sexual side effects. Patients quietly wondering whether something new was wrong with them. They begin changing, they begin describing changes in desire, difficulties with arousal, changes in sexual functioning, and some will assume it has nothing to do with their medication. Others simply too embarrassed to ask. I still remember one patient apologizing before asking whether sexual side effects were worth mentioning. Worth mentioning? Think about that for a moment. Something affecting intimacy, identity, their relationships, their self-confidence. And yet this person had come to believe that it might not be important enough to bring it into the room. I really wish I could tell you this was unusual. It isn't. Patients wondering things like, well, maybe I should just live like this. Is this simply the price of feeling better? Well, my clinician thinks I'm being difficult. Am I supposed to just be grateful the medication is helping? So they try to manage it on their own. They'll do things like reducing the dose, skipping doses. Sometimes they stop treatment altogether. And it's not because they don't value their health, and not because they don't want to get better. But and here's the reason: the burden of the side effect, it's quietly become greater than the benefit they're actually experiencing. So

Weight Gain And What It Means

Dr. Saundra Jain 7:29

let's take a moment, talk about another common side effect: weight gain. You know, patients don't always tell us how deeply it affects them. Again, sometimes they're embarrassed. Sometimes they assume we'll dismiss their concerns. Sometimes they've heard directly or indirectly, things like this. At least the medication is working. But weight gain is never just about a number on a scale. It can shape physical health, influence whether our patients continue treatment. And honestly, it can profoundly affect how people feel about themselves. I remember a patient who had gained a significant amount of weight after starting a medication. And what no one fully appreciated was how much it affected her, how much she no longer recognized herself in the mirror. She talked about how it changed the way she felt walking into a room, her confidence, impact on her intimacy, her willingness to really be seen. She told me she was embarrassed by how much it bothered her. She was ashamed because it sounded vain to her. I mean, what she was thinking is this wasn't she supposed to be grateful the medication was helping? And by the time this sweet woman finally found words for all of that, she'd already decided to stop the medication. So it wasn't simply the weight gain that mattered. It was what the weight gain meant to the person who was experiencing it. And I think that's why, I believe that's why these conversations matter so much. Not after the fact, beforehand. What if we asked, what concerns you most about starting this medicine? What side effects should we be watching for together? Hey, if something changes, how would you like us to talk about it? We might ask, what worries you about starting treatment? What alternative should we consider if this doesn't fit your lifestyle? Because preparing patients for what may happen communicates respect. And even more importantly, it communicates we're in this together. About

Tardive Dyskinesia And Missed Warnings

Dr. Saundra Jain 9:52

10 years ago, I participated in an educational filming project that was focused on tardive dyskinesia. At the time, newer treatment options were emerging, and the project's goal was to capture the lived experiences of these people who had been living with T D for many years. I want you to know, I remember that experience like it was yesterday. It opened my eyes to so many things at the forefront, the devastating impact of TD, social isolation, loss of careers, feelings of shame, fear, stigma. My, the list is very long. And witnessing through their stories the impact that TD had had and was having on their lives, I want you to know it brought me to my knees. I sat in the recording studio with tears running down my face. The cameras, they recorded their stories before treatment and after treatment. And some of the patient's spouses also participated in these conversations. I can still picture those interviews. One theme emerged over and over again. Throughout their years of treatment, not one of them had been, had been in conversation with their clinician about the risk of TD. I remember one woman in particular. She'd received care through her local community mental health system. I believe it was almost 30 years. Think about 30 years. And she shared this that no one had ever discussed the possibility of tardive dyskinesia with her. When she shared that, I just sat in the corner thinking, oh my goodness, how frightening for her, for all of them, to develop these unfamiliar, involuntary movements and have no idea what was wrong or even why it was happening. And then years later, to realize that no one had prepared them for the possibility. Oh my goodness, how isolating and confusing, confusing, absolutely scary, terrifying it must have been for them. The sense of social isolation and aloneness must have been overwhelming. Based on that experience, I really had to turn inward and ask, what have I missed in my conversations with my patients? What questions, fears, or concerns have I overlooked? And let me say, I don't believe that their clinicians intentionally avoided these conversations or intended any harm. Absolutely not. I think we're doing the best we can within systems that often ask us to do more than is humanly possible. But I want you to know listening to those stories, it really changed me. Patients deserve enough information to make choices that align with their values and the lives they hope to live. Not everything, not all at once, but the things that matter, the things they might otherwise end up carrying all alone. Now

How Much Information Is Enough

Dr. Saundra Jain 13:23

we've mentioned weight gain, sexual side effects, involuntary movements, sedation, emotional blunting, sleep changes. Knowing that a side effect is a side effect. It doesn't necessarily mean something new is wrong with them. We're telling and talking about this not to frighten them, but to prepare them. Because fear thrives in uncertainty. And as we all know, understanding creates options. Of course, preparing patients doesn't mean overwhelming them with information. I mean, how much information is enough? Too little leaves us unprepared, and too much may create fear. One patient answered that question better than I ever could. This is what she said to me. I didn't want to Google it. At first I wasn't really sure what she meant. So she went on to explain. I was afraid of what I'd find. She didn't want worst-case scenarios. She wanted someone she trusted to help her understand what mattered. And I remember thinking, perhaps that's one of the gifts we can offer, not certainty, but context, helping our patients distinguish between what is possible, what is probable, and what deserves attention.

Motivational Interviewing Makes Consent Collaborative

Dr. Saundra Jain 14:51

You know, I believe motivational interviewing has something to teach us here. One of its central principles is asking permission before offering information. Instead of assuming, instead of lecturing and giving lots of content, instead of information overload, we simply ask, hey, would it be okay if we talked about some of the risks and benefits of this medication? We might ask, how much detail would be helpful for you today? What concerns you most about starting treatment? Hey, what have you heard that worries you? Suddenly a shift happens. Consent becomes collaborative. It becomes a conversation. Curiosity replaces assumption. And I love this. Patients, listen, they become participants rather than recipients. And perhaps the most important shift of all is this consent stops being a one-time event, and it becomes an ongoing conversation.

Revisiting Consent As Life Changes

Dr. Saundra Jain 15:59

You know, as life circumstances change, side effects emerge, our priorities shift, people age, new evidence becomes available. The conversation continues, it's ongoing. I sometimes wonder what would happen if we routinely revisited consent. Not because anything had gone wrong, but because people change. Priorities change, life changes. The 25-year-old starting treatment may have very different questions at 35. Think about the patient who initially wasn't concerned about weight gain. That may be different 10 pounds later. The person who wasn't thinking about intimacy may suddenly be in a new relationship. So what matters most at the beginning of treatment, it may not be what matters most today. Look, consent isn't static because people aren't static. People cannot consent to what they don't understand. And they can't revisit decisions if they don't know they have permission to revisit them. I often think about how different things might feel if every patient heard something like this. This is our best thinking today. Here's what I believe are the benefits. Here are the risks I want you to understand. Hey, we'll monitor this together. And if something changes, if you notice something different, if you're worried, if you want to reconsider, we will revisit this conversation. I love this because there's no shame, no blame, no fear of disappointing anyone. It's just a collaboration, a partnership. And the truth is, most of our patients don't expect perfection. They don't expect us to predict every possible outcome. But I do think they expect honesty and transparency, and the reassurance that they won't have to navigate uncertainty alone. And perhaps that's what informed consent has always intended to be. Not protection from liability, but protection of dignity, respect for autonomy, an invitation into shared decision making, a conversation that is rooted in trust. I want to thank you for joining me for this episode of the human side of psychopharmacology with Dr. Sondra

Closing Questions And Core Takeaway

Dr. Saundra Jain 18:42

Before we close, I'll leave you with a couple questions. One, what question might your patients be waiting for you to ask? And two, what assumptions might be getting in the way of asking it? Well, my friends, until next time, remember, the medication matters, the diagnosis matters, the evidence matters, but every encounter is therapeutic. And how we show up matters.